The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.
Source link
GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments
Date:
More like thisRelated
‘It all happened so fast,’ Oregon educator who confronted school shooter says
The educator hailed as a hero for throwing a...
Opinion | Michigan’s Political Speech Police
Prop. 2 would expand campaign regulation in vague and...
Halloween 2026: Top athlete costumes around the sports world
It's the spookiest time of the year, and athletes...
Fugitive wanted in New Mexico arrested after 9 years on the run
NEW MEXICO (KRQE) – A fugitive on the run...